I just want to build upon something that you were saying at the end, about the responsibility for physicians to be able to educate their patients and for patients to make an informed decision. In your particular decision that has been made by Health Canada, what types of initiatives or steps have you taken to ensure that patients do receive the right information? Building, I think, upon what Mr. Batters was saying earlier on, what type of educational tools and resources are going to be provided to these women to make an informed choice?
I know you talked a number of times, both in your report and in your discussion, about there being a mandatory reporting requirement. But from everything that you've told the committee, it's the manufacturers that are required to report adverse reactions. First, there are no restrictions on patients reporting those reactions to their surgeons or physicians; and second, there is no mechanism there for the surgeons and physicians to actually go out and report those to the manufacturer. So if a woman out there is experiencing an adverse reaction, the manufacturer may never, ever know about it, and the physician and surgeon may be very hesitant, as this is their bread and butter, to go out and actually report that.
So I would like to know what initiatives Health Canada has taken, in light of all the information available, over a period of four years, to ensure that women in Canada are going to be able to make an informed choice?